A Phase 1 Trial of a Single ProHema® CB Product for Pediatric Patients With Hematologic Malignancies

Clinical trial NCT02354417 · TERMINATED

Trial details

NCT number: NCT02354417
Sponsor: Fate Therapeutics
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Hematologic Malignancies

Start date: 2014-12-01
Primary completion: 2016-12-01
Enrollment: 3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.